Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-020949-26Phase 2Completed
Phase 2 trial of allergovac depot in allergic rhinitis (AR) (2 arms), sponsored by Dr. Miguel Blanca Gómez. Primary endpoint: Efficacy variables. Started Jul 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-020949-26.